Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Statut
Status :
Terminé
Type d'étude
Phase IV
Age Min.
40
Ans
Age Max.
75
Ans
Genre
Tous
Aire thérapeutique :
Rhumatologie
Maladie :
Arthrose
Traitement :
Structum
Phase :
Phase IV
Date de début de l'étude :
17 Novembre 2005
End date :
07 Novembre 2006
Identifiant de l'essai :
L00023 GE 404
Identifiant EudraCT/CTIS :
2005-000508-15
Envoyer par email